# Isolated Abdominal Wall Metastasis of Hepatocellular Carcinoma: A Case Report

**Authors:** Sofia Sequeira, Ana Silva, Inês Peneda Ferreira, Sónia Carvalho, José Presa Ramos

PMC · DOI: 10.7759/cureus.102707 · Cureus · 2026-01-31

## TL;DR

A rare case of liver cancer spreading to the abdominal wall is reported, highlighting the need for long-term monitoring in patients with liver disease.

## Contribution

This case report presents an unusual instance of isolated abdominal wall metastasis from hepatocellular carcinoma unrelated to prior procedures.

## Key findings

- A 74-year-old woman with chronic hepatitis B developed a solitary abdominal wall metastasis from hepatocellular carcinoma.
- The metastasis was confirmed histologically and was anatomically distant from prior surgical and ablation sites.
- No additional metastases were found, and the lesion was successfully surgically excised.

## Abstract

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and typically develops in the setting of chronic liver disease. Extrahepatic metastases usually occur in advanced disease stages and most frequently involve the lungs, bones, and lymph nodes, while metastasis to the abdominal wall is exceedingly rare. We report the case of a 74-year-old woman with chronic hepatitis B-related liver disease who was previously treated with curative-intent hepatectomy and later underwent percutaneous ablation for intrahepatic tumor recurrence. During routine surveillance, a solitary lesion of the right anterolateral abdominal wall was detected and histologically confirmed as metastatic HCC. Importantly, the lesion was anatomically distant from all prior surgical and percutaneous access sites, effectively excluding procedure-related tumor seeding as a mechanism of spread. Comprehensive staging revealed no additional metastatic disease, and the lesion was surgically excised. This case highlights an unusual pattern of extrahepatic dissemination of HCC and emphasizes the importance of careful anatomical assessment and long-term surveillance for the early detection of atypical metastatic disease.

## Linked entities

- **Diseases:** Hepatocellular carcinoma (MONDO:0007256), chronic hepatitis B (MONDO:0005344)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}
- **Diseases:** esophageal varices (MESH:D004932), metabolic-associated fatty liver disease (MESH:D005234), malignancy (MESH:D009369), hepatic fibrosis (MESH:D008103), cirrhosis (MESH:D005355), chronic liver disease (MESH:D008107), intrahepatic disease (MESH:D004194), peritoneal disease (MESH:D010532), alcohol misuse (MESH:D000437), HCC (MESH:D006528), chronic hepatitis B (MESH:D019694), Metastases (MESH:D009362), portal hypertension (MESH:D006975), viral hepatitis (MESH:D014777), abdominal wall lesion (MESH:D046449)
- **Chemicals:** bilirubin (MESH:D001663), entecavir (MESH:C413685)
- **Species:** Hepatitis B virus (no rank) [taxon 10407], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12951811/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12951811/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12951811/full.md

---
Source: https://tomesphere.com/paper/PMC12951811